25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says

At least 25,000 Americans are beginning treatment with Novo Nordisk's Wegovy each week and that figure is growing, the company said. The Danish pharmaceutical giant, which has been ramping up production capacity to meet demand, told FOX Business that there are currently "four times" the number of U.S. patients starting the medication compared with December 2023.

FDA APPROVES ELI LILLY'S TIRZEPATIDE FOR WEIGHT LOSS In order to stay ahead of the competition, the company announced on Thursday that the prices of Wegovy and Ozempic have been dropping. "Following an expanding market access and our focus on reaching more patients, Wegovy net prices declined in the first quarter," Doug Langa, head of Novo Nordisk's North America operations, told analysts during an earnings call.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Wegovy maker Novo Nordisk down 4%, heads for worst day since OctoberAnalysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment.
Source: nbcsandiego - 🏆 524. / 51 Read more »

Wegovy maker Novo Nordisk down 4%, heads for worst day since OctoberAnalysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment.
Source: CNBC - 🏆 12. / 72 Read more »